|
Volumn 164, Issue 10, 2016, Pages 692-693
|
Let's not SPRINT to judgment about new blood pressure goals
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIHYPERTENSIVE AGENT;
ANTIHYPERTENSIVE THERAPY;
BLOOD PRESSURE REGULATION;
CARDIOVASCULAR RISK;
CLINICAL DECISION MAKING;
EVIDENCE BASED PRACTICE;
HUMAN;
HYPERTENSION;
LONG TERM CARE;
PATIENT PREFERENCE;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
RISK REDUCTION;
SHORT SURVEY;
SYSTOLIC BLOOD PRESSURE;
AGED;
CARDIOVASCULAR DISEASE;
COMPLICATION;
DRUG COST;
ECONOMICS;
FEMALE;
MALE;
PRACTICE GUIDELINE;
RISK ASSESSMENT;
RISK FACTOR;
AGED;
ANTIHYPERTENSIVE AGENTS;
CARDIOVASCULAR DISEASES;
CLINICAL DECISION-MAKING;
DRUG COSTS;
FEMALE;
HUMANS;
HYPERTENSION;
MALE;
PRACTICE GUIDELINES AS TOPIC;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
RISK ASSESSMENT;
RISK FACTORS;
|
EID: 84968761647
PISSN: 00034819
EISSN: 15393704
Source Type: Journal
DOI: 10.7326/M15-3123 Document Type: Short Survey |
Times cited : (20)
|
References (9)
|